ChromaCode
Latest round
- Series D
Last raised
- Feb 2023
Total raised
- $88M
Investors
- 11
About ChromaCode
ChromaCode, Inc.Founded in 2012 and headquartered in Carlsbad, US, ChromaCode, Inc. is focused on developing advanced genomic testing solutions. The company has not undergone any significant changes in business strategy. The founders include Aditya Rajagopal and Alex Dickinson, while Mark McDonough serves as the CEO.ChromaCode specializes in its proprietary High-Definition PCR (HDPCR™) multiplexing technology, which enhances genomic testing capabilities by allowing for the simultaneous analysis of multiple DNA and RNA targets. This innovative platform is designed to deliver rapid, cost-effective solutions for oncology and genomic applications, enabling healthcare providers and laboratories to achieve faster turnaround times and improved decision-making. The HDPCR technology facilitates comprehensive tumor profiling and minimal residual disease (MRD) testing, addressing a significant need in patient management by providing access to critical biomarkers.ChromaCode's revenue model is structured around partnerships and direct sales to healthcare providers and laboratories, leveraging its HDPCR technology to enhance their service offerings. The company generates revenue through the sale of reagent kits and access to its cloud-based software, which facilitates data analysis and interpretation of genomic test results. Clients typically engage in B2B transactions, where laboratories purchase these kits to perform advanced genomic assays in their facilities. While specific pricing details for individual products and services are not disclosed, the HDPCR system is noted for its high margins and cost-effective workflows which are advantageous for lab partners.In February 2023, ChromaCode, Inc. Future product launches are anticipated, although specific new products and release dates have not been disclosed.S. and global markets, aiming to improve accessibility to genomic testing technologies for a wider range of healthcare providers.
Who invested in ChromaCode
11 investors across 6 rounds
See all investors in ChromaCode
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ChromaCode
Who invested in ChromaCode?
ChromaCode has 11 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ChromaCode raised?
ChromaCode has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did ChromaCode last raise money?
ChromaCode's most recent round on record is a Series D, in Feb 2023.
What does ChromaCode do?
ChromaCode is a healthcare it company.
Where is ChromaCode headquartered?
ChromaCode is headquartered in Carlsbad, US.
Which VCs invest in companies like ChromaCode?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at ChromaCode's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series D
Raising like ChromaCode? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.